Navigation Links
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
Date:6/10/2008

ules in pre-clinical studies is a major milestone in the Company's goal to develop orally active anti-cancer drugs," said Dr. Richard Salvador, acting President and Chairman of the Board, and the former global head of Preclinical Development at Hoffmann La Roche, Inc.

Dr. Garland, who designed and directed the pre-clinical studies, stated that, "These results confirm the "drugability" of the Id proteins as new and promising anti-tumor targets allowing the Company to move forward to bring the anti-Id molecules into the clinic. The data from the in vitro and in vivo studies not only validate our screening strategy but also confirm their mode of action, a major milestone required for IND filing," he added. "The proprietary small molecule inhibitors of the Id proteins are unlikely to cause serious adverse effects in patients since the main function of the Id proteins is to cause blood vessel formation in the developing fetus and they are not required for the normal activity of the vast majority of cells in the adult. Their major function in adults is to promote blood vessel formation into tumors." As for the next steps, "The program is proceeding with a number of additional in vivo studies including tests in tumor models," according to Dr. Garland, "We will be scrutinizing the data from those tests within the next two or three months as we move these drugs towards the clinic."

Company Profile:

AngioGenex, Inc. is actively engaged in the discovery, acquisition and development of anti-cancer molecules that act by inhibiting either the Id genes or proteins to prevent the formation of new blood vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors, allowing tumors to grow and metastasize. Dr. Benezra de
'/>"/>

SOURCE AngioGenex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. William Garland Joins AngioGenexs New Board of Directors
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2014)... nuclear fuel gets recycled, the process releases radioactive krypton ... basements with the related gas radon. A new porous ... appearing July 20 in Nature Materials shows ... but not out. , The CC3 material could ... from nuclear fuel or air in buildings and also ...
(Date:7/18/2014)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... operating results on Tuesday, August 5, 2014, before the ... conference call and simultaneous webcast at 8:30 AM Eastern ... access this call, dial (888) 660-6127 (U.S.) or (973) ... accessed from the ,Events and Presentations, page of Regeneron,s ...
(Date:7/18/2014)... is mostly neutral. That is, most of the ... number of electrons in the outer parts of atoms ... atoms. As one or more electrons are plucked ... much stronger positive pull from the nucleus. This ... ensures that those electrons are less vulnerable to the ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
Breaking Biology Technology:A noble gas cage 2A noble gas cage 3Highly charged ions 2Highly charged ions 3Highly charged ions 4Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3
... large measure the ability to tune out negativity, author ... of southeastern Wisconsin technology professionals. , ,Kawasaki, managing partner ... "Art of the Start" and several other business books, ... of eInnovate. He poked some good-natured fun at politicians, ...
... may have an expo floor to rival any industry trade show, but ... a sale. , , The BIO Chicago show floor, the size ... globe. "I don't expect any of our end-user customers in the ... of Milwaukee-based Neurognostics said. "This is a probably a better ...
... A stem cell scientist from Harvard University dropped by Wisconsin's ... a hint of admiration, that it was abuzz with activity. ... Wisconsin exhibit than anywhere else I've been on the (exhibit) ... foot traffic at a trade show even one of ...
Cached Biology Technology:Beating back the bozos is an innovation must, says Kawasaki 2As BIO shows mass of competition, hunt for partners is on 2As BIO shows mass of competition, hunt for partners is on 3In competitive biotech world, Wisconsin can't afford to fall behind 2In competitive biotech world, Wisconsin can't afford to fall behind 3
(Date:7/21/2014)... and Dr. Mary Lou Applewhite Distinguished Professor in Department ... to an article in the scientific journal Nature ... into Primate Biology and Evolution," published on July 20. ... mobile elements that move by a sort of "copy ... important because it is the first "New World" monkey ...
(Date:7/21/2014)... La. Dr. Mark DeCoster, the James E. ... Louisiana Tech University, will present as an invited ... at the Biopolis Research and Development Center in ... faculty member in Louisiana Tech,s Institute for Micromanufacturing, ... 2D and 3D cell and tissue models." ...
(Date:7/21/2014)... see an innovation and think, "Of course! Why didn,t ... thoughts of our own invention, sparking ideas and building ... the International Space Station Program Science Office,s new 15-book ... have going on in orbit, their mental wheels may ... encourage investigators to propose new research and potentially make ...
Breaking Biology News(10 mins):LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome 2Louisiana Tech University professor presents at International Bioprinting Congress 2International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4
... at the Southwest Foundation for Biomedical Research (SFBR) in ... levels of bad cholesterol to accumulate in the blood ... studied a strain of laboratory opossums developed at SFBR ... (LDL) cholesterol when fed a standard low-cholesterol diet, but ...
... 14, 2010: 5:00 p.m. U.S. Eastern Time) A new ... groups reveals an ominous finding: most of the world,s ... tradeare now clustered in just six percent of their ... scattered across Asia that are now the last hope ...
... published in the Sept. 15 edition of the Journal ... Edward H. Shortliffe, MD, PhD, points out that although ... role that information management and access play in healthcare ... informatics competency being developed in America,s future corps of ...
Cached Biology News:Scientists find gene for high cholesterol in blood 2Last strongholds for tigers identified in new study 2Last strongholds for tigers identified in new study 3Informatics = essential MD competency 2
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
Gap junction protein, beta 2, 26kDa (connexin 26) Antigen: Peptide...
IKKbeta/IKK-2 Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Reacts with human. Tested in Western blotting....
Biology Products: